LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 70.08 | 27.76 | 9796 | 6849 | 1.4301 | 1.0921 | MN20160318_Q01 | N09 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 71.78 | 27.76 | 7790 | 6893 | 1.1301 | 1.0310 | MN20160318_Q01 | J06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 71.78 | 27.76 | 7872 | 6893 | 1.1420 | 1.0337 | MN20160318_Q01 | J06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 71.78 | 27.76 | 8521 | 6893 | 1.2362 | 1.0540 | MN20160318_Q01 | N09 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 71.78 | 27.76 | 10126 | 6893 | 1.4690 | 1.0991 | MN20160318_Q01 | N09 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 73.48 | 27.76 | 7755 | 6957 | 1.1146 | 1.0274 | MN20160318_Q01 | J06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 73.48 | 27.76 | 7853 | 6957 | 1.1287 | 1.0306 | MN20160318_Q01 | J06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 73.48 | 27.76 | 7657 | 6957 | 1.1005 | 1.0242 | MN20160318_Q01 | N09 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 73.48 | 27.76 | 10257 | 6957 | 1.4742 | 1.0998 | MN20160318_Q01 | N09 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 75.19 | 27.76 | 7748 | 7015 | 1.1045 | 1.0251 | MN20160318_Q01 | J06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 75.19 | 27.76 | 7848 | 7015 | 1.1187 | 1.0283 | MN20160318_Q01 | J06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 75.19 | 27.76 | 7964 | 7015 | 1.1353 | 1.0320 | MN20160318_Q01 | N09 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 75.19 | 27.76 | 10427 | 7015 | 1.4864 | 1.1018 | MN20160318_Q01 | N09 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 76.89 | 27.76 | 7771 | 7025 | 1.1062 | 1.0254 | MN20160318_Q01 | J06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 76.89 | 27.76 | 7877 | 7025 | 1.1212 | 1.0289 | MN20160318_Q01 | J06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 76.89 | 27.76 | 7515 | 7025 | 1.0697 | 1.0170 | MN20160318_Q01 | N09 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 76.89 | 27.76 | 10520 | 7025 | 1.4975 | 1.1038 | MN20160318_Q01 | N09 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 78.60 | 27.76 | 7756 | 7045 | 1.1008 | 1.0242 | MN20160318_Q01 | J06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 78.60 | 27.76 | 7880 | 7045 | 1.1184 | 1.0282 | MN20160318_Q01 | J06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 78.60 | 27.76 | 7309 | 7045 | 1.0374 | 1.0092 | MN20160318_Q01 | N09 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 78.60 | 27.76 | 10690 | 7045 | 1.5172 | 1.1072 | MN20160318_Q01 | N09 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 80.31 | 27.76 | 7731 | 6976 | 1.1082 | 1.0259 | MN20160318_Q01 | J06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 80.31 | 27.76 | 7910 | 6976 | 1.1339 | 1.0318 | MN20160318_Q01 | J06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 80.31 | 27.76 | 6691 | 6976 | 0.9591 | 0.9896 | MN20160318_Q01 | N09 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 80.31 | 27.76 | 10825 | 6976 | 1.5517 | 1.1133 | MN20160318_Q01 | N09 |